Rani Therapeutics Holdings, Inc. - Class A Common Stock, Par Value $.0001 (RANI)

CUSIP: 753018100

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / Class A Common Stock, Par Value $.0001
Shares outstanding
98,437,808
Total 13F shares
2,885,407
Share change
-225,880
Total reported value
$17,024,416
Price per share
$5.90
Number of holders
32
Value change
-$1,472,942
Number of buys
14
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 753018100?
CUSIP 753018100 identifies RANI - Rani Therapeutics Holdings, Inc. - Class A Common Stock, Par Value $.0001 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Rani Therapeutics Holdings, Inc. - Class A Common Stock, Par Value $.0001 (RANI) as of Q4 2022

As of 31 Dec 2022, Rani Therapeutics Holdings, Inc. - Class A Common Stock, Par Value $.0001 (RANI) was held by 32 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,885,407 shares. The largest 10 holders included VANGUARD GROUP INC, Alphabet Inc., Nan Fung Group Holdings Ltd, UNITED SERVICES AUTOMOBILE ASSOCIATION, Alpha Square Group S, LLC, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, BlackRock Inc., MOTCO, and TPB WEALTH ADVISORS. This page lists 32 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.